Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696282 | PMC |
| http://dx.doi.org/10.1016/j.infpip.2021.100189 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CT imaging findings of invasive pulmonary fungal infections in hemato-oncologic children.
Insights Imaging
December 2024
Department of Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Hemato-oncologic children form a heterogeneous group with a wide spectrum of ages, malignancy types, and immunosuppression grades during the different phases of their treatment. Immunosuppression is caused by multiple factors, including the malignancy itself, bone marrow suppression secondary to therapy, and wide use of steroids and antibiotics, among others. At the same time, the risk of infections in these patients remains high because of prolonged hospitalizations or the need for long-timing implanted devices between other features.
View Article and Find Full Text PDFSafety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.
Antimicrob Agents Chemother
December 2024
Children's Hospital of Orange County, Orange, and University of California, Irvine, California, USA.
Article Synopsis
- Invasive aspergillosis (IA) and mucormycosis (IM) significantly affect severely ill patients, prompting the approval of isavuconazonium sulfate for treating these fungal infections in both adults and recently in children.
- A phase 2 study involved 31 pediatric patients across multiple countries, revealing a 54.8% overall response rate to treatment and a low 6.5% all-cause case fatality at 42 days.
- Although 93.5% of participants experienced treatment-emergent adverse events (TEAEs), the drug was generally well tolerated, and dosing conformed to safety standards previously established in adult studies.
Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology.
J Clin Microbiol
December 2024
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Article Synopsis
Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by infection secondary to acute myeloid leukemia: a case report.
Front Med (Lausanne)
October 2024
Department of Infectious Diseases, Shangyu People's Hospital of Shaoxing, Shaoxing, Zhejiang, China.
Cutaneous mucormycosis is a rare fungal infection marked by skin abscesses, swelling, necrosis, dry ulcers, and eschars. Though less fatal compared to other mucormycosis forms, delayed diagnosis and treatment in immunocompromised patients can cause the infection to spread to vital organs, becoming life-threatening. We report a case of lower extremity cutaneous mucormycosis secondary to acute myeloid leukemia, successfully managed with sustained surgical debridement and short-term oral posaconazole.
View Article and Find Full Text PDFCOVID-19-Associated Neurological Complications in Children.
Iran J Child Neurol
September 2024
Department of Peadiatrics, Ramaiah Medical College, Bangalore, India.
Objectives: Neurological manifestations of Severe Acute Respiratory Syndrome coronavirus-2 have been well documented in adults during and after infection with the virus as well as after vaccination. The incidence of severe neurological symptoms among children is very low. This study aimed to analyze the varied neurological manifestations after COVID-19 infection among children and give a report on a single-center experience with these severe neurological symptoms.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!